IL162524A0 - Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application - Google Patents

Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application

Info

Publication number
IL162524A0
IL162524A0 IL16252403A IL16252403A IL162524A0 IL 162524 A0 IL162524 A0 IL 162524A0 IL 16252403 A IL16252403 A IL 16252403A IL 16252403 A IL16252403 A IL 16252403A IL 162524 A0 IL162524 A0 IL 162524A0
Authority
IL
Israel
Prior art keywords
terapeutic
pyridin
octane
derivatives
preparation
Prior art date
Application number
IL16252403A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of IL162524A0 publication Critical patent/IL162524A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL16252403A 2002-01-07 2003-01-03 Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application IL162524A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
PCT/FR2003/000004 WO2003057697A1 (fr) 2002-01-07 2003-01-03 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
IL162524A0 true IL162524A0 (en) 2005-11-20

Family

ID=8871176

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16252403A IL162524A0 (en) 2002-01-07 2003-01-03 Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
IL162524A IL162524A (en) 2002-01-07 2004-06-14 Derivatives of 5- (pyridin- 3 - yl)-1 - azabicyclo [3.2.1] octane, their preparation and their therapeutic application

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162524A IL162524A (en) 2002-01-07 2004-06-14 Derivatives of 5- (pyridin- 3 - yl)-1 - azabicyclo [3.2.1] octane, their preparation and their therapeutic application

Country Status (36)

Country Link
US (2) US7223750B2 (zh)
EP (1) EP1465893B1 (zh)
JP (1) JP4402957B2 (zh)
KR (1) KR100977332B1 (zh)
CN (2) CN1911928A (zh)
AR (2) AR038098A1 (zh)
AT (1) ATE355290T1 (zh)
AU (1) AU2003216777B2 (zh)
BR (1) BR0306707A (zh)
CA (1) CA2471628C (zh)
CO (1) CO5590914A2 (zh)
CY (1) CY1106580T1 (zh)
DE (1) DE60312123T2 (zh)
DK (1) DK1465893T3 (zh)
EA (1) EA007793B1 (zh)
EC (1) ECSP045176A (zh)
ES (1) ES2281631T3 (zh)
FR (1) FR2834511B1 (zh)
HK (1) HK1066547A1 (zh)
HR (1) HRP20040617B1 (zh)
IL (2) IL162524A0 (zh)
IS (1) IS2470B (zh)
MA (1) MA27165A1 (zh)
ME (2) MEP24408A (zh)
MX (1) MXPA04006630A (zh)
NO (1) NO329309B1 (zh)
NZ (1) NZ533793A (zh)
PL (1) PL216665B1 (zh)
PT (1) PT1465893E (zh)
RS (1) RS50921B (zh)
SI (1) SI1465893T1 (zh)
TN (1) TNSN04120A1 (zh)
TW (1) TWI336703B (zh)
UA (1) UA77229C2 (zh)
WO (1) WO2003057697A1 (zh)
ZA (1) ZA200405002B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) * 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101925971B1 (ko) * 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
AU2018362010B2 (en) 2017-11-03 2021-05-13 Alcon Inc. Azabicyclo and diazepine derivatives for treating ocular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
AU7474794A (en) 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2786770B1 (fr) 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr) 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
KR20040077705A (ko) 2004-09-06
CA2471628C (en) 2011-03-22
ECSP045176A (es) 2004-08-27
RS50921B (sr) 2010-08-31
TWI336703B (en) 2011-02-01
EP1465893B1 (fr) 2007-02-28
EA200400770A1 (ru) 2004-12-30
MA27165A1 (fr) 2005-01-03
AU2003216777A1 (en) 2003-07-24
CY1106580T1 (el) 2012-01-25
UA77229C2 (uk) 2006-11-15
IL162524A (en) 2010-05-17
AU2003216777B2 (en) 2008-10-02
CN1612876A (zh) 2005-05-04
EA007793B1 (ru) 2007-02-27
HK1066547A1 (en) 2005-03-24
US20050020568A1 (en) 2005-01-27
DE60312123T2 (de) 2007-09-13
NO329309B1 (no) 2010-09-27
FR2834511A1 (fr) 2003-07-11
TW200305413A (en) 2003-11-01
NZ533793A (en) 2007-01-26
CO5590914A2 (es) 2005-12-30
EP1465893A1 (fr) 2004-10-13
HRP20040617B1 (hr) 2012-10-31
NO20042846L (no) 2004-09-21
HRP20040617A2 (en) 2004-10-31
AR038098A1 (es) 2004-12-29
IS2470B (is) 2008-12-15
BR0306707A (pt) 2005-02-09
CN1911928A (zh) 2007-02-14
TNSN04120A1 (fr) 2006-06-01
PL370065A1 (en) 2005-05-16
US20070185137A1 (en) 2007-08-09
CA2471628A1 (en) 2003-07-17
WO2003057697A1 (fr) 2003-07-17
PT1465893E (pt) 2007-05-31
MEP24408A (en) 2010-10-10
SI1465893T1 (sl) 2007-08-31
ME00213B (me) 2011-02-10
PL216665B1 (pl) 2014-04-30
JP2005514422A (ja) 2005-05-19
FR2834511B1 (fr) 2004-02-13
US7223750B2 (en) 2007-05-29
ES2281631T3 (es) 2007-10-01
ZA200405002B (en) 2006-05-31
MXPA04006630A (es) 2004-11-10
JP4402957B2 (ja) 2010-01-20
RS59904A (en) 2006-10-27
DE60312123D1 (de) 2007-04-12
KR100977332B1 (ko) 2010-08-20
DK1465893T3 (da) 2007-06-04
US7585974B2 (en) 2009-09-08
ATE355290T1 (de) 2006-03-15
CN1276921C (zh) 2006-09-27
AR086573A2 (es) 2014-01-08
IS7322A (is) 2004-06-16

Similar Documents

Publication Publication Date Title
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
IL191960A (en) History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HUP0401718A3 (en) Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
HK1081964A1 (en) Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
HK1081954A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
TWI319400B (en) Piperazinylacylpiperidine derivatives, their preparation and their therapeutic application
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
PL374761A1 (en) N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
HUP0400154A3 (en) Heterocondesated benzoxazepine and benzoxathiazepine derivatives, their use and pharmaceutical compositions containing them
MXPA03006162A (es) Derivados de mikanolida, su preparacion y sus usos terapeuticos.
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
PL362573A1 (en) Imidazolidine derivatives, their preparation, and their use as antinflamatory agent.
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
HUP0402149A3 (en) Water-soluble phenylpyridazine derivatives, their use and pharmaceutical compositions containing the same
HK1063793A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2002313036A1 (en) Novel 5-thio-B-D-xylopyranoside Derivatives, Preparation Method Thereof, Pharmaceutical Compositions Containing Same and the Therapeutic Use Thereof
EG23305A (en) Preparation of 1,2-dicloroethane.
AU2002355351A1 (en) Acylaminothiazole derivatives, their preparation and therapeutic use